Autopsy report · NCT00511966

Influence of Hygiene-dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With Rabeprazol

“Due to the achievement of minimum required sample size and new changes in local regulations.”

The sponsor’s own words in the registry.

Life of this trial

• 1,049 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Janssen-Cilag, S.A.

Sponsor type

Industry

Conditions

Gastroesophageal Reflux

Interventions

Non-Pharmacologic Treatment; Rabeprazole

Participants

1,049

Trials that died the same way

• Time To Complications Occurs in Diabetes
  “Local regulations” (55% match in meaning)
• Intra-Operative Corticosteroid Injection During Arthroscopic Shoulder Surgery
  “It was difficult to recruit patients to get the appropriate sample size.” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.